The Leading Beyond The Lab Podcast is hosted by Lawrence Rose, one of the Directors at ARTO, a talent solutions agency specialising in leadership roles within the Life Sciences sector globally.
This podcast provides insightful discussions with industry experts, leaders and innovators, shaping the future in drug development and clinical devices. We talk with biotechnology and/or pharmaceutical executives, and find out from them their stories, personal career development and analyse their opinion on how to become successful in this space. We talk on a range of topics including soft skills, oncology, leadership, micromanagement, investment, cardiology, AI, dementia, addiction, hematology, dermatology, and much more.
This podcast applies broadly to all types of connections in the Life Sciences Industry, and aims to educate and inspire those who want to excel in leadership.
Hosted on Acast. See acast.com/privacy for more information.
The Leading Beyond The Lab Podcast is hosted by Lawrence Rose, one of the Directors at ARTO, a talent solutions agency specialising in leadership roles within the Life Sciences sector globally.
This podcast provides insightful discussions with industry experts, leaders and innovators, shaping the future in drug development and clinical devices. We talk with biotechnology and/or pharmaceutical executives, and find out from them their stories, personal career development and analyse their opinion on how to become successful in this space. We talk on a range of topics including soft skills, oncology, leadership, micromanagement, investment, cardiology, AI, dementia, addiction, hematology, dermatology, and much more.
This podcast applies broadly to all types of connections in the Life Sciences Industry, and aims to educate and inspire those who want to excel in leadership.
Hosted on Acast. See acast.com/privacy for more information.
This episode is a masterclass in how world-class life sciences investors think about risk, conviction, and real patient impact.
This week on Leading Beyond The Lab, Lawrence Rose sat down with Nikhil Thatte, Partner at Lumira Ventures, a leading Canadian life sciences venture capital firm, with over a decade of experience backing transformative biotech and medtech companies across North America.
In this conversation, Nikhil shares how Lumira Ventures has built a top-quartile VC track record over multiple market cycles, investing across therapeutic areas including oncology, gene editing, gene therapy, immunology, cardiometabolic disease, and medical devices. He also reflects on his journey helping scale globally impactful healthcare companies while staying grounded in patient outcomes.
In this episode, Nikhil covers:
• How Lumira Ventures evaluates investment opportunities in today’s biotech market, including why clinical data, valuation discipline, and a clear path to liquidity now matter more than ever (08:38)
• Lessons from Lumira’s major exit successes, including Histosonics and Endotronix, and what made these companies stand out from an investor perspective, with insights into leadership, timing, and execution alongside Mike Blue at Histosonics (02:33)
• What truly differentiates exceptional founders and management teams, with real examples of conviction moments backing leaders such as Joanna Stanicka at Axonis and Jade Doucet-Martineau at Puzzle Med (22:08)
• Why Canada punches above its weight in life sciences innovation, the structural challenges holding the ecosystem back, and what must change to retain value domestically, including reflections on Canadian success stories discussed throughout the episode (17:40)
• The vision behind the Cancer Breakthrough Fund, Lumira’s partnership with the Terry Fox Foundation, and how this model brings new capital, clinical expertise, and impact-driven investors into oncology innovation (31:08)
If you want a rare, honest look inside how top life sciences VCs assess opportunity, leadership, and long-term value creation, this is an episode you don’t want to miss.
Follow ARTO: https://linktr.ee/arto_talent
Nikhil Thatte
LinkedIn: https://www.linkedin.com/in/nikhil-thatte-72372333/
Lawrence Rose
Director at ARTO
LinkedIn: https://www.linkedin.com/in/lawrencerose/
Timestamps:
00:00 Introduction to Nikhil Thatte and Lumira Ventures
02:33 Major exits including Histosonics and Endotronix
05:30 Fund V and what drives LP conviction today
08:38 How Lumira evaluates deals in the current biotech market
17:40 Canada’s competitive advantages and ecosystem challenges
22:08 Backing exceptional founders and leadership teams
31:08 The Cancer Breakthrough Fund and Terry Fox Foundation partnership
37:00 Technologies and trends shaping the next 5–10 years
41:16 Patient impact and what ultimately motivates long-term investing
#LeadingBeyondTheLab #ARTOTalent #LifeSciences #BiotechVC #Medtech #VentureCapital #CanadianInnovation
Hosted on Acast. See acast.com/privacy for more information.
Cardio-metabolic diseases are the world’s biggest killer. But what if the next generation of treatments could change everything?
This week on Leading Beyond The Lab, Lawrence Rose sat down with Jyothis George, CMO of Nodthera, and a global thought leader in the obesity space, shaping the future of cardio-metabolic and inflammatory disease innovation. Jyothis has led global programs across GLP-1, SGLT2, PCSK9 and now the emerging NLRP3 inhibitor class. His work spans companies such as Novo Nordisk, Amgen, Boehringer Ingelheim and his move into biotech with NodThera marks a shift from big-Pharma leadership into next-wave therapeutic development.
In this episode, Jyothis covers:
- How NodThera is shaping the future of metabolic and inflammatory disease treatment.
- A look at the mindset and challenges behind leading in a high-stakes biotech environment.
- Why the right investors often play a critical mentorship role in biotech growth.
- Exploring why endocrinology remains underfunded and overlooked in biotech circles.
- How he previously worked with Eli Lilly (led by David Ricks), contributing to their efforts in the cardiometabolic space.
- Reflections on personal legacy, long-term impact, and how to get in touch.
If you’re interested in cardio-metabolic innovation, GLP-1 evolution, biotech strategy or leadership at the cutting edge of science, this episode is worth your time.
Follow ARTO
LinkedIn: https://www.linkedin.com/company/artotalent
Spotify: https://open.spotify.com/show/0kEcRZOiJChOoN1KF2n1ng
Instagram: https://www.instagram.com/arto.talent?igsh=MWdhbWl5N204a253NQ%3D%3D&utm_source=qr
TikTok: https://www.tiktok.com/@artotalent?_t=ZG-8tHbGACAZaj&_r=1
Apple Podcasts: https://podcasts.apple.com/us/podcast/leading-beyond-the-lab/id1783115575
Website: https://arto-talent.com
Youtube: https://www.youtube.com/@life_sciences
Jyothis George
CMO at NodThera
LinkedIn: https://www.linkedin.com/in/jyothisgeorge/
Lawrence Rose
Co-Founder + Talent Solutions Director At ARTO
LinkedIn: https://www.linkedin.com/in/lawrencerose/
Timestamps:
01:40 NodThera's Role in Future Endocrinology
10:48 Leadership in Biotech
21:05 Investment and Mentorship
30:58 Endocrinology's Underinvestment
38:13 Jyothis George: Legacy & Contact
Hosted on Acast. See acast.com/privacy for more information.
25 years of life sciences venture experience in one episode.
This week on Leading Beyond The Lab, @Lawrence Rose sat down with @Joey Mason, a venture investor with 25 years of experience across venture debt, venture capital and company building. Joey’s background spans senior roles with @Claret Capital Partners, @Sofinnova Partners, and earlier positions in investment banking and CRO services. His track record includes multiple successful exits, advising boards, working across Medtech, Biotech, digital health and Techbio, and supporting companies through regulatory approval, clinical development and commercial scale.
In this episode, Joey covers:
Check out this episode if you want a grounded, practical understanding of how life sciences companies are assessed, funded and supported behind the scenes, and how founders can communicate, hire and plan more effectively on the path to scale.
Follow ARTO!
LinkedIn: https://www.linkedin.com/company/artotalent
Spotify: Leading Beyond The Lab
Instagram: Instagram (@arto.talent)
TikTok: artotalent on TikTok
Apple Podcasts: Leading Beyond The Lab
Website: Home
Youtube: ARTO Recruitment
Lawrence Rose
Co-Founder + Talent Solutions Director at @ARTO
LinkedIn: https://www.linkedin.com/in/lawrencerose/
Joey Mason
Venture Advisor @Sofinnova
Venture Partner @Claret Capital Partners
LinkedIn: https://www.linkedin.com/in/joey-mason/
Timestamps
01:09 Joey’s Career
05:14 Investment approaches
19:17 Most successful investment
28:20 Leadership
32:46 How to pitch to Joey Mason
42:21 Future plans
#LeadingBeyondTheLab #ARTOTalent #LifeSciences #VentureCapital #VentureDebt #Medtech #Biotech #TechBio #DigitalHealth #IrelandEcosystem #Pharma #InvestmentStrategy
Hosted on Acast. See acast.com/privacy for more information.
🤔 What does it really take to build a biotech that survives the clinical gauntlet and scales into a global business?
🎬 This week on Leading Beyond The Lab, Lawrence Rose sat down with Roel Bulthuis, Managing Partner and Head of Investments at Syncona Limited.
Roel has spent his career building, funding and scaling European biotech companies end-to-end, supporting high-performing teams from inception through clinical development, commercial launch and manufacturing scale-up.
Along the way he references outcomes from portfolio companies such as Autolus Therapeutics and Beacon Therapeutics, showing how patient capital and conviction-led strategy compound over time.
⭐️ Syncona has an impressive portfolio including,
Autolus Therapeutics, Beacon Therapeutics, Spur Therapeutics, iOnctura, Quell Therapeutics, ANAVEON AG, MOSAIC THERAPEUTIC SERVICES, Resolution Therapeutics, Purespring Therapeutics, Forcefield Therapeutics, OMass Therapeutics, Kesmalea Therapeutics, Yellowstone Biosciences, Slingshot Therapeutics.
🚀 In this episode, Roel dives into:
- What defines a Syncona company and its unique model
- Key lessons learned from both successes and setbacks
- How to manage investor involvement without stifling progress
- The challenges of leadership transitions within portfolio companies
- Syncona’s strategic commitment to the European market
- What drives Roel personally and what he enjoys most about his role
Check out this episode if you want grounded insight into biotech venture building, long-term capital strategy and how scientific founders scale from the lab to patient impact. 🤝
Follow ARTO!
LinkedIn: https://www.linkedin.com/company/artotalent
Spotify: https://open.spotify.com/show/0kEcRZOiJChOoN1KF2n1ng
Instagram: https://www.instagram.com/arto.talent?igsh=MWdhbWl5N204a253NQ%3D%3D&utm_source=qr
TikTok: https://www.tiktok.com/@artotalent?_t=ZG-8tHbGACAZaj&_r=1
Apple Podcasts: https://podcasts.apple.com/us/podcast/leading-beyond-the-lab/id1783115575
Website: https://arto-talent.com
Youtube: https://www.youtube.com/@life_sciences
Lawrence Rose
Co-Founder + Talent Solutions Director at @ARTO
LinkedIn: https://www.linkedin.com/in/lawrencerose/
Role Bulthuis
Managing Partner @Syncona
LinkedIn: https://www.linkedin.com/in/roel-bulthuis-aa414a/
Timestamps:
01:10 What makes up a Syncona company?
11:25 What were the main lessons learnt from previous failures/successes?
15:06 Managing investor involvement & preventing counter productivity.
22:14 The issues with exchanging leadership.
31:07 Commitment to the European Market.
42:20 What Roel enjoys about his job.
Hosted on Acast. See acast.com/privacy for more information.
A once-in-a-century transformation, and the leader driving it.
This week, in one of our biggest episode of Leading Beyond the Lab yet, we sit down with Christophe Bourdon, CEO of LEO Pharma, a company valued in the multi-billion-euro range and entering one of the most defining chapters in its 100-year history.
With over 25+ years of global biopharma leadership experience, spanning pivotal roles at Amgen, Sanofi, and Orphazyme, Christophe brings a rare combination of commercial excellence, turnaround leadership, and global market insight. He also shares how senior leaders such as Murdo Gordon helped shape his approach to building high-performing, people-centric teams.
In this episode, Host of Leading Beyond The Lab, @Lawrence Rose, discusses with Christophe how he’s reshaping a century-old European company into a modern, innovation-driven global leader, covering:
This episode is a rare look at what it truly takes to modernise a legacy company while keeping innovation, collaboration, and leadership at the core.
Be sure to check out this episode - one of our most important conversations to date.
Follow ARTO
LinkedIn: https://www.linkedin.com/company/artotalent
Spotify: Leading Beyond The Lab
Instagram: Instagram (@arto.talent)
TikTok: artotalent on TikTok
Apple Podcasts: Leading Beyond The Lab
Website: Home
Youtube: ARTO Recruitment
Christophe Bourdon
CEO of LEO Pharma
LinkedIn: https://www.linkedin.com/in/christophe-bourdon-77a62b6/
Lawrence Rose
Co-Founder + Talent Solutions Director At ARTO
LinkedIn: https://www.linkedin.com/in/lawrencerose/
Timestamps:
00:00 LEO’S Recent Achievements
06:58 Shaping a Modern LEO Pharma
16:30 LEO Pharma’s IPO Journey
25:39 Christophe’s Leadership
Hosted on Acast. See acast.com/privacy for more information.
What does it take to shape a high-impact biotech investment portfolio - and do it under a medical charity mandate?
This week we sit down with Clare Terlouw, Head of LifeArc Ventures, whose 20+ year career spans investment banking, biotech company building, and leading venture teams focused on health innovation. With a unique perspective at the intersection of science, capital, and patient impact, Clare shares a candid and optimistic view of the evolving biotech landscape in the UK and beyond.
In this episode, Clare covers:
- LifeArc Ventures’ mission: how a medical charity is driving returns while staying true to a patient-first vision.
- Investing and scaling biotech: from early inflection points to Series B and beyond, what great companies get right.
- Biotech in the UK: challenges in the current funding environment, the talent surge, and why optimism still holds.
- Tech-enabled drug discovery: how AI, computational biology, and new business models are shaping investment priorities.
- Clare's leadership lens: her personal drive, how she evaluates opportunity, and the power of staying focused on patient outcomes.
Be sure to check out this episode if you're interested in the future of biotech investing, the rise of tech-enabled therapeutics, and how one venture leader is backing science that matters.
Follow ARTO
LinkedIn: https://www.linkedin.com/company/artotalent
Spotify: https://open.spotify.com/show/0kEcRZOiJChOoN1KF2n1ng
Instagram: https://www.instagram.com/arto.talent?igsh=MWdhbWl5N204a253NQ%3D%3D&utm_source=qr
TikTok: https://www.tiktok.com/@artotalent?_t=ZG-8tHbGACAZaj&_r=1
Apple Podcasts: https://podcasts.apple.com/us/podcast/leading-beyond-the-lab/id1783115575
Website: https://arto-talent.com
Youtube: https://www.youtube.com/@life_sciences
Clare Terlouw
Managing Partner at Life Arc
LinkedIn: https://www.linkedin.com/in/clare-terlouw-b608aa17/
Lawrence Rose
Co-Founder + Talent Solutions Director At ARTO
LinkedIn: https://www.linkedin.com/in/lawrencerose/
Timestamps:
00:00 Life Arc - Investments + Impact
09:44 Investing in and Growing a Company
17:52 Biotech in the UK
26:18 Tech Enabled Drug Discovery
32:57 Clare Terlouw
Hosted on Acast. See acast.com/privacy for more information.
If you're not paying attention to nuclear medicine, Danielle Meyrick will change that in under five minutes.
This week, we sit down with Dr. Danielle Meyrick, Director and Co-Founder at EPIC Theranostics, to explore the meteoric rise of nuclear medicine and radiotheranostics. With over 20 years of experience spanning academia, biotech, and hospital environments, Danielle is uniquely positioned as both a scientific pioneer and commercial strategist. Her career has spanned from launching radiopharmaceutical therapies in hospitals to shaping global strategies for biotech companies. If you're serious about understanding the future of oncology, this is the episode to watch. In this episode we cover:
If you're in biotech, pharma, or medtech, this episode is a masterclass in strategic thinking and scientific depth. Watch now and get ahead of where oncology is going.
Follow ARTO
LinkedIn: https://www.linkedin.com/company/artotalent
Spotify: Leading Beyond The Lab
Instagram: Instagram (@arto.talent)
TikTok: artotalent on TikTok
Apple Podcasts: Leading Beyond The Lab
Website: Home
Youtube: ARTO Recruitment
Danielle Meyrick
Co-Founder + Director At EPIC Theranostiocs
LinkedIn: https://www.linkedin.com/in/arndt-schottelius-md-ph/
Lawrence Rose
Co-Founder + Talent Solutions Director At ARTO
LinkedIn: https://www.linkedin.com/in/lawrencerose/
Timestamps:
00:00 Career Beginnings
06:12 Nuclear Medicine
09:26 Characteristics of a Good Drug Developer
14:13 Future of Radiotheranostics
20:05 Approaching Challenges
26:52 Advice
29:25 Motivations
30:56 Greatest Achievements
#LeadingBeyondTheLab #ARTOTalent #Biotechnology
Hosted on Acast. See acast.com/privacy for more information.
Two of the most influential minds in immuno-oncology walk into a biotech… and build something that could change everything.
Dr. Rachel Humphrey (CEO) and Dr. Melinda Merchant (CMO) of Normunity are two of the most seasoned and respected leaders in oncology drug development, with a combined 45+ years of experience across big pharma, biotech, and translational science. Rachel led the development of Yervoy® (ipilimumab) at BMS, Imfinzi® (durvalumab) at AstraZeneca, and Nexavar® (sorafenib) at Bayer, before holding CMO roles at Black Diamond, Mirati, and CytomX. Melinda, an immunologist and dual board-certified pediatric oncologist, spent a decade leading clinical studies at NIH and Memorial Sloan Kettering, running early trials of ipilimumab, nivolumab, and novel cell therapies before moving to industry and leading clinical development efforts of multiple investigational new drugs. Together, they now lead Normunity, where they’re pioneering a bold new therapeutic category: immune normalizers - designed to unlock immune resistance and open up new frontiers in cancer treatment.In this episode, we cover:
- How Normunity is redefining immuno-oncology with its first-in-class T-cell engager
- What it takes to build scientific teams that challenge each other - and still move fast
- Lessons from launching Yervoy, Imfinzi, Tazverik, and other breakthrough therapies
- Why biotech culture needs both humility and ego to succeed
- What’s next as Normunity prepares to enter the clinic with NRM-823
If you're a life sciences leader, founder, or investor - this conversation is essential listening. Tap in to hear what it really takes to build, lead, and scale science that matters.
Follow ARTO
LinkedIn: https://www.linkedin.com/company/artotalent
Spotify: https://open.spotify.com/show/0kEcRZOiJChOoN1KF2n1ng
Instagram: https://www.instagram.com/arto.talent?igsh=MWdhbWl5N204a253NQ%3D%3D&utm_source=qr
TikTok: https://www.tiktok.com/@artotalent?_t=ZG-8tHbGACAZaj&_r=1
Apple Podcasts: https://podcasts.apple.com/us/podcast/leading-beyond-the-lab/id1783115575
Website: https://arto-talent.com
Youtube: https://www.youtube.com/@life_sciences
Rachel Humphrey
CEO at Normunity
LinkedIn: https://www.linkedin.com/in/rachel-w-humphrey-md-116b211b/
Melinda Merchant
CMO at Normunity
LinkedIn: https://www.linkedin.com/in/melinda-merchant-7b496a/
Lawrence Rose
Co-Founder + Talent Solutions Director At ARTO
LinkedIn: https://www.linkedin.com/in/lawrencerose/
Timestamps:
00:00 Career Beginnings
16:58 Traits of a Drug Developer
19:53 Leadership in Biotech
27:28 Story Behind Normunity
30:23 Normunity Culture
32:28 Mindsets in Translational Science
36:33 Personal Life
#LeadingBeyondTheLab #ARTOTalent #Biotechnology
Hosted on Acast. See acast.com/privacy for more information.
Dr. Arndt Schottelius, CEO of Maxion Therapeutics, is a physician-scientist with a standout career across Genentech, MorphoSys, Kymab, and now at one of the UK’s most promising biotech companies. At Maxion, he leads a team pioneering KnotBody technology - an innovative approach to targeting ion channels and GPCRs, long considered “undruggable” with biologics. Arndt brings more than 25 years of experience across translational science, drug development and leadership in global R&D. His conviction, clarity, and track record - including developing molecules that have become partnered, acquired and approved - makes this conversation a must-listen for anyone in life sciences leadership.
In this episode, we cover:
Tune in for a dynamic, insightful conversation with one of biotech’s most experienced and thoughtful leaders.
Follow ARTO
LinkedIn: https://www.linkedin.com/company/artotalent
Spotify: Leading Beyond The Lab
Instagram: Instagram (@arto.talent)
TikTok: artotalent on TikTok
Apple Podcasts: Leading Beyond The Lab
Website: Home
Youtube: ARTO Recruitment
Arndt Schottelius
CEO at Maxion Theraprutics
LinkedIn: https://www.linkedin.com/in/arndt-schottelius-md-ph/
Lawrence Rose
Co-Founder + Talent Solutions Director At ARTO
LinkedIn: https://www.linkedin.com/in/lawrencerose/
Timestamps:
00:00 Career Beginnings
06:46 Translational Science
08:55 Lessons in Biotech Leadership
25:23 Maxion - Culture and Roundup
#LeadingBeyondTheLab #ARTOTalent #Biotechnology
Hosted on Acast. See acast.com/privacy for more information.
If you want to understand what it really takes to build and lead a successful biotech, this episode is for you.
Dr. Christopher Morabito, Chief Medical Officer at Astria Therapeutics, joins us to share hard-won lessons from 25 years in rare disease, oncology, and immunology. But this isn’t a career retrospective - it’s a deep dive into the mindset, strategies, and leadership habits that drive biotech success.
In this episode, Chris reveals:
Chris distills decades of experience into practical, actionable advice for founders, executives, and investors - making this one of the most insightful conversations we’ve had yet.
🎧 Tune in for a rare, candid look at biotech leadership from someone who’s been on the front lines of game-changing therapies.
Follow ARTO
LinkedIn: https://www.linkedin.com/company/artotalent
Spotify: Leading Beyond The Lab
Instagram: Instagram (@arto.talent)
TikTok: artotalent on TikTok
Apple Podcasts: Leading Beyond The Lab
Website: Home
Youtube: ARTO Recruitment
Christopher Morabito
CMO at Astria Therapeutics
LinkedIn: https://www.linkedin.com/in/chrismorabito/
Lawrence Rose
Co-Founder + Talent Solutions Director At ARTO
LinkedIn: https://www.linkedin.com/in/lawrencerose/
Timestamps:
00:00 Career Beginnings
13:40 Moving Into Biotech
23:34 Leading in Biotech
28:41 Patients First
38:23 Lessons & Legacy
#LeadingBeyondTheLab #ARTOTalent #Biotechnology
Hosted on Acast. See acast.com/privacy for more information.
If you're in biotech, immunology, or drug development - this is the episode you’ve been waiting for.
We’re joined by Dr. Bhaskar Srivastava, Chief Medical Officer at Triveni Bio, whose career has spanned over 10 years across J&J, Nimbus, and now Triveni Bio, one of the most ambitious autoimmune biotech startups on the scene.
In this episode, Bhaskar dives deep into:
· How Triveni is building a first-in-class pipeline targeting the kallikrein system - a bold bet to treat severe skin and inflammatory conditions by tackling novel biology.
· What it means to be a founder’s CMO, and how great science needs the right development strategy to make a difference.
· Candid stories from his past roles at Nimbus (which sold its TYK2 program to Takeda for $4B) and Janssen, where he helped guide first-in-class therapies from Phase 1 to pivotal trials.
· Why bispecifics may be risky but worth it, and how Triveni is using novel biologics to crack tough diseases like atopic dermatitis.
· Advice for executives: how to balance ambition and discipline, when to say no, and why choosing the right team members matters as much as the science.
🎙 Bhaskar doesn’t just talk science - he connects molecular biology to patient need, clinical strategy, and company vision with clarity and purpose.
Follow ARTO
LinkedIn: https://www.linkedin.com/company/artotalent
Spotify: Leading Beyond The Lab
Instagram: Instagram (@arto.talent)
TikTok: artotalent on TikTok
Apple Podcasts: Leading Beyond The Lab
Website: Home
Youtube: ARTO Recruitment
Bhaskar Srivastava
CMO at Triveni Bio
LinkedIn: https://www.linkedin.com/in/bhaskar-srivastava-355a9ab1/
Lawrence Rose
Co-Founder + Talent Solutions Director At ARTO
LinkedIn: https://www.linkedin.com/in/lawrencerose/
Timestamps:
00:00 Career Beginnings
15:44 Success & Growth in Biotech
28:43 Investing in Biotech
34:23 The Future of Dermatology & Triveni Bio
#LeadingBeyondTheLab #ARTOTalent #Biotechnology
Hosted on Acast. See acast.com/privacy for more information.
If you care about the future of genomics, diagnostics, and biotech investing, you can’t miss this episode.
We’re joined by Mara Aspinall, Partner at Illumina Ventures, a trailblazer with over 30 years of leadership in diagnostics and eight years in venture capital funding groundbreaking genomics companies.
In this episode, Mara reveals:
With her unmatched experience as an operator, educator, and investor, Mara brings clarity, energy, and vision to a fast-changing field. This conversation is packed with takeaways for founders, investors, and anyone fascinated by the future of healthcare.
🎧 Tune in now for a masterclass in diagnostics, genomics, and venture capital from one of the industry’s most influential voices.
Follow ARTO
LinkedIn: https://www.linkedin.com/company/artotalent
Spotify: Leading Beyond The Lab
Instagram: Instagram (@arto.talent)
TikTok: artotalent on TikTok
Apple Podcasts: Leading Beyond The Lab
Website: Home
Youtube: ARTO Recruitment
Mara Aspinall
Partner At Illumina Ventures
LinkedIn: https://www.linkedin.com/in/mara-aspinall-6688142/
Lawrence Rose
Co-Founder + Talent Solutions Director At ARTO
LinkedIn: https://www.linkedin.com/in/lawrencerose/
Timestamps:
00:00 Career Beginnings
04:10 Current Diagnostic Trends
20:48 The Founder Investor Fit
25:37 Genetics & Genomics
29:06 Mara Aspinall
39:31 Neurodegenerative Disease
#LeadingBeyondTheLab #ARTOTalent #Biotechnology
Hosted on Acast. See acast.com/privacy for more information.
To anyone interested in life science VC investment – you need to watch this.
In this episode, we’re joined by Dr. Sascha Berger, a biotech investment director based in Saudi Arabia and a very experienced life science investor globally. With nearly two decades in the industry, he’s seen breakthroughs, pivots, and billion-dollar transactions.
He reveals:
This is one of our most unfiltered and insightful episodes yet - a must-watch for founders, investors, or anyone who wants to see where life sciences is really heading.
🎧 Tune in now to hear how a leading investor is driving biotech’s next era.
Follow ARTO
LinkedIn: https://www.linkedin.com/company/artotalent
Spotify: Leading Beyond The Lab
Instagram: Instagram (@arto.talent)
TikTok: artotalent on TikTok
Apple Podcasts: Leading Beyond The Lab
Website: Home
Youtube: ARTO Recruitment
Sascha Berger
Saudi Arabia Biotech Investor
LinkedIn: https://www.linkedin.com/in/sasber/
Lawrence Rose
Co-Founder + Talent Solutions Director At ARTO
LinkedIn: https://www.linkedin.com/in/lawrencerose/
Timestamps:
00:00 Career Beginnings
08:04 Investing in Success
26:13 Saudi Arabia - The Future
36:29 How to Secure Investment
#LeadingBeyondTheLab #ARTOTalent #Biotechnology #Dermatology
Hosted on Acast. See acast.com/privacy for more information.
In this episode, we sit down with Dr. Tomoko Maeda-Chubachi - a global leader in dermatology drug development and biotech innovation:
In this episode, we discuss a range of topics, including her career beginnings, challenges that come with drug development, leadership in biotech, key achievements and much more. This conversation applies broadly to all types of connections in the Life Sciences Industry, and aims to educate and inspire those who want to excel in leadership.
Follow ARTO
LinkedIn: https://www.linkedin.com/company/artotalent
Spotify: Leading Beyond The Lab
Instagram: Instagram (@arto.talent)
TikTok: artotalent on TikTok
Apple Podcasts: Leading Beyond The Lab
Website: Home
Youtube: ARTO Recruitment
Tomoko Maeda-Chubachi
CMO at Kalm Therapeutics + Boardroom Ready at Women in Bio
LinkedIn: https://www.linkedin.com/in/tomoko-maeda-chubachi/
Lawrence Rose
Co-Founder + Talent Solutions Director At ARTO
LinkedIn: https://www.linkedin.com/in/lawrencerose/
Timestamps:
00:00 Career Beginnings
06:23 Drug Development
08:59 Leadership
13:58 Achievements + Fractional CMO
#LeadingBeyondTheLab #ARTOTalent #Biotechnology #Dermatology
Hosted on Acast. See acast.com/privacy for more information.
In this episode, we sit down with Nicholas Reder, who’s pushing the boundaries in AI-driven spatial tissue analysis, with a mix of experience and insights:
In this episode, we discuss a range of topics including Alpenglow’s current success and what the future looks like, hiring talent within techbios, as well and leadership challenges within the computational biology space. This conversation applies broadly to all types of connections in the Life Sciences Industry, and aims to educate and inspire those who want to excel in leadership.
Follow ARTO
LinkedIn: https://www.linkedin.com/company/artotalent
Spotify: Leading Beyond The Lab
Instagram: Instagram (@arto.talent)
TikTok: artotalent on TikTok
Apple Podcasts: Leading Beyond The Lab
Website: Home
Youtube: ARTO Recruitment
Nicholas Reder
Founder + CEO at Alpenglow Biosciences
LinkedIn: https://www.linkedin.com/in/nicholas-reder-210a578b/
Lawrence Rose
Co-Founder + Talent Solutions Director At ARTO
LinkedIn: https://www.linkedin.com/in/lawrencerose/
Timestamps:
00:00 Career Beginnings & Alpenglow
04:54 AI & Hiring Talent
14:58 Challenges / Key Triggers When Hiring
19:36 Alpenglow Biosciences
24:14 What’s Next - Quickfire Round
#LeadingBeyondTheLab #ARTOTalent #Biotechnology #Dermatology
Hosted on Acast. See acast.com/privacy for more information.
In this episode, we sit down with Dr. Bernardo Cervantes, leading the charge in microbiome science, with a mix of experience and insights:
In this episode, we discuss the future of microbiome sciences, Bernardo’s key learnings throughout his career, how he’s adapted his leadership as one of three Co-Founders, management, a great opportunity within the market and a lot more. This conversation applies broadly to all types of connections in the Life Sciences Industry, and aims to educate and inspire those who want to excel in leadership.
Follow ARTO
LinkedIn: https://www.linkedin.com/company/artotalent
Spotify: Leading Beyond The Lab
Instagram: Instagram (@arto.talent)
TikTok: artotalent on TikTok
Apple Podcasts: Leading Beyond The Lab
Website: Home
Youtube: ARTO Recruitment
Dr. Bernardo Cervantes
Chief Operations Officer at Concerto Biosciences
LinkedIn: https://www.linkedin.com/in/bernacularbio/
Lawrence Rose
Co-Founder + Talent Solutions Director At ARTO
LinkedIn: https://www.linkedin.com/in/lawrencerose/
Timestamps:
00:00 Career Beginnings & Concerto Biosciences
10:16 Concerto Biosciences - Key Learnings
15:26 Team Building & Culture
23:52 Quickfire Questions
#LeadingBeyondTheLab #ARTOTalent #Biotechnology #Dermatology
Hosted on Acast. See acast.com/privacy for more information.
In this episode, we sit down with Dr. Frank Watanabe, a titan of biotech and pharma, and leader shaping the future of medicine:
In this episode, we discuss everything from How Frank built Arcutis, motivation and Self-Improvement that is grounded from his experience in the Navy, revealing the key to success as a leader in the industry. This conversation applies broadly to all types of connections in the Life Sciences Industry, and aims to educate and inspire those who want to excel in leadership.
Follow ARTO
LinkedIn: https://www.linkedin.com/company/artotalent
Spotify: Leading Beyond The Lab
Instagram: Instagram (@arto.talent)
TikTok: artotalent on TikTok
Apple Podcasts: Leading Beyond The Lab
Website: Home
Youtube: ARTO Recruitment
Dr. Frank Watanabe
President, CEO At Arcutis
LinkedIn: https://www.linkedin.com/in/frank-watanabe-419711/
Lawrence Rose
Co-Founder + Talent Solutions Director At ARTO
LinkedIn: https://www.linkedin.com/in/lawrencerose/
Timestamps:
00:00 Career Beginnings + Arcutis
05:01 Leadership & Growth
20:52 Motivation & Self Improvement
27:40 Personality Traits To Succeed In Pharma
33:30 What’s Next For Arcutis
#LeadingBeyondTheLab #ARTOTalent #Biotechnology #Dermatology
Hosted on Acast. See acast.com/privacy for more information.
In this episode, we sit down with Dr. Volker Koscielny, a distinguished figure in the pharmaceutical industry, with a wealth of experience and a forward thinking approach to medical innovation:
In this episode, we discuss the future of dermatology, Volker’s insights from industry roundtables, and the key experiences and achievements that shaped his success in the field. This conversation applies broadly to all types of connections in the Life Sciences Industry, and aims to educate and inspire those who want to excel in leadership.
Follow ARTO
LinkedIn: https://www.linkedin.com/company/artotalent
Spotify: Leading Beyond The Lab
Instagram: Instagram (@arto.talent)
TikTok: artotalent on TikTok
Apple Podcasts: Leading Beyond The Lab
Website: Home
Youtube: ARTO Recruitment
Dr. Volker Koscielny
Chief Medical Officer at Almirall
LinkedIn: https://www.linkedin.com/in/volker-koscielny/
Lawrence Rose
Co-Founder + Talent Solutions Director At ARTO
LinkedIn: https://www.linkedin.com/in/lawrencerose/
Timestamps:
00:00 Leadership In Life Sciences
10:40 Potential In Dermatology
16:21 Functionality As A Leader
22:40 Achievements & Wrapping Up
#LeadingBeyondTheLab #ARTOTalent #Biotechnology #Dermatology
Hosted on Acast. See acast.com/privacy for more information.
In this episode, we sit down with Dr. Brian Kim, a true trailblazer at the cutting edge of science and medicine:
In this episode, we discuss everything from Innovation & AI in dermatology to Leadership in Academia vs Industry. Brian also reveals the reason Dermatology is securing so much funding in 2025. This conversation applies broadly to all types of connections in the Life Sciences Industry, and aims to educate and inspire those who want to excel in leadership.
Follow ARTO
LinkedIn: https://www.linkedin.com/company/artotalent
Spotify: Leading Beyond The Lab
Instagram: Instagram (@arto.talent)
TikTok: artotalent on TikTok
Apple Podcasts: Leading Beyond The Lab
Website: Home
Youtube: ARTO Recruitment
Dr. Brian Kim
Co-Founder At Alys Pharmaceuticals
LinkedIn: https://www.linkedin.com/in/brian-s-kim-4605662/
Lawrence Rose
Co-Founder + Talent Solutions Director At ARTO
LinkedIn: https://www.linkedin.com/in/lawrencerose/
Timestamps:
00:00 Innovation & AI
11:08 Communication & Motivation
23:58 Leadership in Industry VS Academia
35:32 Why Dermatology Secures Funding
49:29 Quickfire Questions
#LeadingBeyondTheLab #ARTOTalent #Biotechnology #Dermatology #Immunology
Hosted on Acast. See acast.com/privacy for more information.
In this episode, we sit down with Dr. Juergen Reess, a Board-Certified Neurologist with an incredible career spanning over 20 years in corporate and drug development leadership roles at Boehringer Ingelheim. After an extensive career in big pharma, Juergen transitioned into the world of biotech, where he now plays a pivotal role in shaping the future of medicine.
Juergen is the Founder & CEO of MoglingBio Inc, an innovative company in the longevity space, pioneering novel pharmacological approaches to rejuvenate old stem cells, a field with immense potential. As well as this, Juergen is also the Fractional CMO of SciRhom, a Munich-based clinical-stage biotech tackling autoimmune diseases with iRhom2-targeting therapies, where they have just secured a €63M Series A funding round to propel their groundbreaking work.
In this insightful conversation, we explore, how Juergen kick-started his career in life sciences, how he kept his career "fresh" in a big pharma setting by taking on new challenges, the challenges and adaptions from transitioning from big pharma to biotech, lessons from founding and funding his own biotech ventures, what "Longevity" really means in the biotech world, how he adapts across various therapeutic areas and much more.
This episode is packed with valuable insights for anyone in life sciences, whether you're a scientist, entrepreneur, investor, or industry leader. Don't miss this inspiring discussion on innovation, adaptability, and leadership in biotech!
Follow ARTO
LinkedIn: https://www.linkedin.com/company/artotalent
Spotify: Leading Beyond The Lab
Instagram: Instagram (@arto.talent)
TikTok: artotalent on TikTok
Apple Podcasts: Leading Beyond The Lab
Website: Home
Youtube: ARTO Recruitment
Dr. Juergen Reess
LinkedIn: https://www.linkedin.com/in/juergen-reess-b443468/
Lawrence Rose
Co-Founder + Talent Solutions Director At ARTO
LinkedIn: https://www.linkedin.com/in/lawrencerose/
Timestamps:
00:00 Career Beginnings
10:23 Shifting to Biotech
16:13 Founding a Biotech
21:15 Communicating with Investors
24:41 AI in Life Sciences
#LeadingBeyondTheLab #ARTOTalent #Biotechnology #Oncology #Neurology
Hosted on Acast. See acast.com/privacy for more information.